ADIPOQ and hepatocellular carcinoma: Contrary to circulating adiponectin, which seems to be increased in HCC, showing a positive association with HCC risk and a negative association with HCC survival in most clinical studies, data on the adiponectin expression in HCC tissue are conflicting.